|
Detailed information for selected cell line:
| Cell Line: |
SZ-Rb2 PGD, Retinoblastoma mutation
|
| NIH Registration Number: |
0418
|
| NIH Approval Number: |
NIHhESC-20-0418
|
| Available for Distribution: |
Yes
|
| Provider Restrictions: |
For non-commercial research purpose only; cannot be used for the generation of germ line transmitting chimeras, request for an MTA that specifies the proposed research. Cannot be used for the creation of functional gametes, the generation of interspecies chimeras, and human cloning.
|
| Additional Information: |
The embryo from which the hESC line was established was found to be heterozygous for the C1572insAA mutation in the Rb gene (predisposition for Retinoblastoma) by PGD.
|
| NIH Restrictions: |
(No Additional Restrictions)
|
| Submitting Organization: |
Shaare Zedek Medical Center |
| Provider Name: |
Rachel Eiges
|
| Provider Phone: |
+972-26666721
|
| Provider Email: |
rachela@szmc.org.il
|
| Provider URL: |
|
| Approval Date: |
05/29/2020 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
| |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
